Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Sep;61(9):3730-8.
doi: 10.1128/iai.61.9.3730-3738.1993.

Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells

Affiliations

Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells

I Müller et al. Infect Immun. 1993 Sep.

Abstract

CD8+ T cells have been shown to contribute to the rapid resolution of secondary lesions developing in immune mice challenged with Leishmania major. In the present study, we assessed directly the participation of specific CD8+ T cells in the memory response induced in immune mice by reinfection. Lymphocyte populations from reinfected immune mice exhibit marked secondary gamma interferon (IFN-gamma) responses. The participation of IFN-gamma-producing CD8+ T cells in the memory response elicited by secondary infectious challenge was demonstrated in both genetically resistant immune CBA mice and genetically susceptible immune BALB/c mice that were rendered resistant by administration of anti-CD4 monoclonal antibody in the early phase of the primary infection. The protective function of CD8+ T cells in experimental murine cutaneous leishmaniasis might thus be explained in part by their ability to secrete IFN-gamma. In this context, the neutralization of IFN-gamma at the time of reinfection reduced the Leishmania-specific delayed-type hypersensitivity response, showing that this cytokine is involved in the recall of immunological memory to L. major in vivo.

PubMed Disclaimer

References

    1. Parasite Immunol. 1985 Sep;7(5):545-55 - PubMed
    1. Res Immunol. 1991 Sep;142(7):573-6 - PubMed
    1. J Exp Med. 1986 Jul 1;164(1):363-8 - PubMed
    1. J Immunol. 1987 Aug 15;139(4):1303-9 - PubMed
    1. J Exp Med. 1987 Nov 1;166(5):1229-44 - PubMed

Publication types